| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |